Market Share of Japan Diabetes Drugs Industry
The Japan Diabetes Drugs Market is consolidated, with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, and other generic players, holding a presence in the region. A major share of the market is held by manufacturers concomitant with strategy-based M&A operations and constantly entering the market to generate new revenue streams and boost existing ones.
Japan Diabetes Drugs Market Leaders
Takeda
AstraZeneca
Boehringer Ingelheim
Novo Nordisk A/S
Sanofi Aventis
*Disclaimer: Major Players sorted in no particular order
